New Frontier Health akcijos akcijų analizė | Akcijų kaina | Naujienos | NFH | KYG6461G1064 |

Data	New Frontier Health Akcijų kaina
2022-01-26	75,60 undefined
2022-01-25	75,46 undefined

Data	New Frontier Health Pajamos	New Frontier Health EBIT	New Frontier Health Pelnas
2025e	4,78 mlrd. undefined	919,29 mln. undefined	715,00 mln. undefined
2024e	4,50 mlrd. undefined	737,80 mln. undefined	372,01 mln. undefined
2023e	4,04 mlrd. undefined	499,46 mln. undefined	195,49 mln. undefined
2022e	3,48 mlrd. undefined	337,90 mln. undefined	73,51 mln. undefined
2021e	2,96 mlrd. undefined	184,26 mln. undefined	−62,06 mln. undefined
2020	2,26 mlrd. undefined	−78,41 mln. undefined	−505,57 mln. undefined
2019	2,45 mlrd. undefined	−208,80 mln. undefined	−429,30 mln. undefined
2018	0 undefined	−5,10 mln. undefined	14,40 mln. undefined

	Pajamos	EBIT	Pelnas
2018	0 CNY	−5,10 mln. CNY	14,40 mln. CNY
2019	2,45 mlrd. CNY	−208,80 mln. CNY	−429,30 mln. CNY
2020	2,26 mlrd. CNY	−78,41 mln. CNY	−505,57 mln. CNY
2021e	2,96 mlrd. CNY	184,26 mln. CNY	−62,06 mln. CNY
2022e	3,48 mlrd. CNY	337,90 mln. CNY	73,51 mln. CNY
2023e	4,04 mlrd. CNY	499,46 mln. CNY	195,49 mln. CNY
2024e	4,50 mlrd. CNY	737,80 mln. CNY	372,01 mln. CNY
2025e	4,78 mlrd. CNY	919,29 mln. CNY	715,00 mln. CNY

2018	2019	2020	2021e	2022e	2023e	2024e	2025e
0	2,45	2,26	2,96	3,48	4,04	4,50	4,78
-	-	−7,72	30,93	17,71	15,85	11,47	6,27
-	83,67	81,42	-	-	-	-	-
0	2,05	1,84	0	0	0	0	0
−5,00	−208,00	−78,00	184,00	337,00	499,00	737,00	919,00
-	−8,49	−3,45	6,22	9,68	12,37	16,39	19,23
14,00	−429,00	−505,00	−62,00	73,00	195,00	372,00	715,00
-	−3 164,29	17,72	−87,72	−217,74	167,12	90,77	92,20
40,50	131,40	131,36	0	0	0	0	0
-	-	-	-	-	-	-	-

2018	2019	2020

0,02	1,35	0,64
0	215,00	218,97
0	67,00	10,13
0	57,00	92,27
0	415,00	53,51
0,02	2,11	1,02
0	3,74	3,67
2,00	0	0,00
0	0	0
0	2,59	2,53
0	6,06	6,09
0	165,00	120,16
2,00	12,54	12,40
2,01	14,65	13,42

1,93	0	0,00
0,02	8,43	8,28
15,00	0	0
0	−259,00	−822,90
0	0	0
1,96	8,17	7,46
2,00	99,00	89,06
1,00	973,00	515,12
0	290,00	354,69
0	400,00	6,03
0	0	0
0,00	1,76	0,96
0	2,06	2,05
0	682,00	665,96
0,05	1,74	2,06
0,05	4,48	4,78
0,05	6,24	5,74
2,01	14,41	13,21

2018	2019	2020
14,00	−396,00	−504,00
0	344,00	425,00
0	0	0
2,00	65,00	−72,00
−19,00	222,00	416,00
0	208,00	176,00
0	76,00	44,00
−2,00	236,00	265,00
0	−387,00	−312,00
−1 901,00	−387,00	−319,00
−1 901,00	0	−6,00
0	0	0
0	−22,00	−631,00
1,95	0	0
1,92	−0,20	−0,63
−32,00	−177,00	-
0	0	0
15,00	−350,00	−712,00
0	0	0
0	0	0

New Frontier Health Bruto marža	New Frontier Health Pelnas-martža	New Frontier Health EBIT marža	New Frontier Health Pelnas-martža
2025e	81,40 %	19,23 %	14,96 %
2024e	81,40 %	16,40 %	8,27 %
2023e	81,40 %	12,38 %	4,84 %
2022e	81,40 %	9,70 %	2,11 %
2021e	81,40 %	6,23 %	−2,10 %
2020	81,40 %	−3,47 %	−22,37 %
2019	83,66 %	−8,53 %	−17,53 %
2018	81,40 %	0 %	0 %

	Bruto marža	EBIT marža	Pelnas-martža
2018	81,40 %	0 %	0 %
2019	83,66 %	−8,53 %	−17,53 %
2020	81,40 %	−3,47 %	−22,37 %
2021e	81,40 %	6,23 %	−2,10 %
2022e	81,40 %	9,70 %	2,11 %
2023e	81,40 %	12,38 %	4,84 %
2024e	81,40 %	16,40 %	8,27 %
2025e	81,40 %	19,23 %	14,96 %

Data	New Frontier Health Pardavimai vienai akcijai	New Frontier Health EBIT vienai akcijai	New Frontier Health Pelnas vienai akcijai
2025e	36,25 undefined	0 undefined	5,42 undefined
2024e	34,11 undefined	0 undefined	2,82 undefined
2023e	30,60 undefined	0 undefined	1,48 undefined
2022e	26,42 undefined	0 undefined	0,56 undefined
2021e	22,44 undefined	0 undefined	−0,47 undefined
2020	17,21 undefined	−0,60 undefined	−3,85 undefined
2019	18,64 undefined	−1,59 undefined	−3,27 undefined
2018	0 undefined	−0,13 undefined	0,36 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2018	0 CNY	−0,13 CNY	0,36 CNY
2019	18,64 CNY	−1,59 CNY	−3,27 CNY
2020	17,21 CNY	−0,60 CNY	−3,85 CNY
2021e	22,44 CNY	0 CNY	−0,47 CNY
2022e	26,42 CNY	0 CNY	0,56 CNY
2023e	30,60 CNY	0 CNY	1,48 CNY
2024e	34,11 CNY	0 CNY	2,82 CNY
2025e	36,25 CNY	0 CNY	5,42 CNY

	Akcijų skaičius
2018	40,50 mln. Aktien
2019	131,40 mln. Aktien
2020	131,36 mln. Aktien
2021e	131,36 mln. Aktien
2022e	131,36 mln. Aktien
2023e	131,36 mln. Aktien
2024e	131,36 mln. Aktien
2025e	131,36 mln. Aktien

%	Pavadinimas	Akcijos	Pokytis	Data
7,13 %	Fosun International Ltd	9 400 000	0	2021-12-02
6,33 %	Nan Fung Group Holdings Ltd	8 350 000	0	2021-12-02
5,74 %	Capital Research Global Investors	7 562 063	−3 051 358	2021-09-30
4,11 %	Oasis Management Company Ltd.	5 421 271	377 223	2021-09-30
32,48 %	New Frontier Public Holding, Ltd.	42 820 875	0	2021-12-02
3,90 %	MY.Alpha Management HK Advisors Limited	5 137 507	5 137 507	2021-12-02
3,70 %	Brave Peak Ltd	4 875 000	0	2021-12-02
3,10 %	Aspex Management (HK) Limited	4 081 250	0	2021-12-02
3,04 %	Morgan Stanley Investment Management (Singapore)	4 003 801	0	2021-09-30
2,72 %	Lipson (Roberta)	3 590 799	0	2021-12-02
2,64 %	BlueCrest Capital Management LLP	3 485 845	785 000	2021-09-30
2,50 %	Maso Capital Partners Limited	3 299 142	−380 163	2021-09-30
2,39 %	Advance Data Services Ltd	3 150 000	0	2021-12-02
2,28 %	Smart Scene Investment Ltd	3 000 000	0	2021-12-02
10,85 %	Vivo Capital, LLC	14 300 000	0	2021-12-02
1,93 %	Baron Capital Management, Inc.	2 541 395	−18 933	2021-09-30
1,77 %	York Capital Management L P.	2 331 067	−2 457 419	2021-10-05
1,73 %	Yunqi China Special Investment A	2 278 316	0	2021-12-02
1,65 %	Leung (Antony Kam Chung)	2 175 000	0	2021-12-02
1,61 %	Smart Will Investments Ltd	2 125 000	0	2021-12-02
1,15 %	Wellington Management Company, LLP	1 521 439	99 535	2021-09-30
0,85 %	LY Holdings, L.L.C.	1 125 000	0	2021-12-02
0,82 %	Wu (Carl)	1 087 500	0	2021-12-02
0,81 %	Bardin Hill Investment Partners LP	1 065 868	262 291	2021-09-30
0,80 %	Pentwater Capital Management LP	1 060 000	−459 704	2021-09-30
0,78 %	Junson Development International Ltd	1 026 910	0	2021-12-02
0,62 %	Maven Investment Partners Ltd	814 430	21 826	2021-09-30
0,60 %	Apex Strategic Ventures Ltd	787 500	0	2021-12-02
0,59 %	Fidelity Management & Research Company LLC	777 997	71 797	2021-09-30
0,57 %	BNP Paribas Asset Management USA, Inc.	755 817	0	2021-11-30
0,54 %	UBS O'Connor LLC	716 265	0	2021-09-30
0,54 %	Verition Fund Management LLC	706 837	706 837	2021-09-30
0,49 %	Fidelity Management & Research (Hong Kong) Limited	646 296	0	2021-11-30
0,45 %	Renaissance Technologies LLC	593 225	32 100	2021-09-30
0,44 %	GLG Partners LP	584 066	245 207	2021-09-30
0,27 %	Segantii Capital Management Limited	350 000	0	2021-09-30
0,24 %	Owl Creek Asset Management, L.P.	321 300	0	2021-09-30
0,23 %	Millennium Management LLC	308 537	308 537	2021-09-30
0,23 %	K2 Advisors L.L.C.	307 876	144 379	2021-09-30
0,17 %	Golden Majestic Investments Ltd	219 250	500	2021-12-02
0,16 %	Zeng (David Ph.D)	206 250	75 000	2020-12-31
0,14 %	Qube Research & Technologies Ltd	190 524	102 116	2021-09-30
0,13 %	Star Advantage Global Ltd	168 750	0	2021-12-02
0,13 %	Zeng (Ying)	168 750	0	2021-12-02
0,12 %	Yakira Capital Management, Inc.	162 205	162 205	2021-09-30
0,11 %	MFS Investment Management	146 682	−10 339	2021-08-31
0,10 %	Chatham Asset Management, L.L.C.	129 738	0	2021-11-30
0,09 %	Fidelity Investments Canada ULC	113 530	113 530	2021-09-30
0,08 %	HSBC Global Asset Management (UK) Limited	107 168	107 168	2021-09-30
0,08 %	Credit Suisse International	102 626	102 626	2021-09-30
0,08 %	State Street Global Advisors (US)	101 099	41 179	2021-09-30
0,07 %	Credit Suisse Asset Management	87 493	0	2021-09-30
0,06 %	Prelude Capital Management, LLC	81 600	0	2021-09-30
0,06 %	Ergoteles Capital	78 196	78 196	2021-09-30
0,05 %	Privium Fund Management (UK) Ltd	70 000	70 000	2021-09-30
0,05 %	Xue (Walter)	62 088	0	2020-12-31
0,05 %	S. Muoio & Co. LLC	60 000	40 000	2021-09-30
0,05 %	Strategic Vision Investment Limited	60 000	60 000	2021-09-30
0,04 %	China International Fund Management Co., Ltd.	49 990	8 471	2020-12-31
0,04 %	Ersel Asset Management SGR S.p.A.	49 486	−3	2021-11-30
0,04 %	Goldman Sachs & Company, Inc.	46 798	46 798	2021-09-30
0,04 %	Goldman Sachs Asset Management, L.P.	46 245	20 717	2021-10-31
0,03 %	Camelot Portfolios, LLC	41 000	41 000	2021-09-30
0,03 %	Mercer Global Investments Management Ltd	40 367	4 719	2020-12-31
0,03 %	Allianz Global Investors GmbH	35 000	0	2021-09-30
0,02 %	AllianceBernstein Japan Ltd.	27 008	−325	2021-03-31
0,02 %	Oaktree Capital Management, L.P.	24 080	0	2020-09-30
0,02 %	Marshall Wace LLP	22 652	22 652	2021-09-30
0,02 %	Jump Financial, LLC	21 000	21 000	2021-09-30
0,02 %	Susquehanna Fundamental Investments, LLC	20 900	20 900	2021-09-30
0,01 %	SG Americas Securities, L.L.C.	18 268	18 268	2021-09-30
0,01 %	China Universal Asset Management Co., Ltd.	15 900	15 900	2020-12-31
0,01 %	UBS Financial Services, Inc.	15 552	14 934	2021-09-30
0,01 %	JBF Capital, Inc.	13 000	13 000	2021-09-30
0,01 %	Veritas Investment Associates S.A.S.	12 500	5 000	2021-05-31
0,01 %	Arrowstreet Capital, Limited Partnership	11 501	−83 190	2021-09-30
0,01 %	Banca del Sempione SA	10 000	10 000	2021-03-31
0,01 %	Che Hung (Edward Leong)	10 000	0	2020-12-31
0,01 %	Wolverine Asset Management, LLC	8 235	3 343	2021-09-30
0,01 %	Advisor Group, Inc	7 600	−600	2021-09-30
0,00 %	Penserra Capital Management LLC	6 271	−14 228	2021-09-30
0,00 %	Northern Trust Investments, Inc.	5 830	5 830	2021-12-31
0,00 %	Morgan Stanley Investment Management Ltd. (UK)	5 692	965	2021-09-30
0,00 %	BofA Global Research (US)	5 487	−93 785	2021-09-30
0,00 %	Daiwa Asset Management Co., Ltd.	1 013	1 013	2021-09-30
0,00 %	Tower Research Capital LLC	140	−1 589	2021-09-30
0,00 %	RBC Capital Partners	113	−114	2021-09-30
0 %	Windsor Creek Advisors, LLC	0	−128 893	2021-03-31
0 %	Occudo Quantitative Strategies LP	0	−15 698	2021-09-30
0 %	J.P. Morgan Securities LLC	0	−5 111	2021-03-31
0 %	AllianceBernstein L.P.	0	−975 169	2021-03-31
0 %	California Public Employees' Retirement System	0	−34 563	2021-09-30
0 %	RBC Capital Markets Wealth Management	0	−100	2021-03-31
0 %	Morgan Stanley & Co. LLC	0	−24 085	2021-09-30
0 %	Morgan Stanley Investment Management Inc. (US)	0	−2 238 058	2021-06-30
0 %	Piper Sandler & Co.	0	−2 400	2020-12-31
0 %	BNP Paribas Asset Management France SAS	0	−26 592	2021-11-30
0 %	JPMorgan Asset Management U.K. Limited	0	−49 990	2021-03-31
0 %	HSBC Global Asset Management (Hong Kong) Limited	0	−100 000	2021-06-30
0 %	Tudor Investment Corporation	0	−21 387	2021-09-30

Pavadinimas	Santykis	Dviejų savaičių koreliacija	Vieno mėnesio koreliacija	Trymėnesio koreliacija	Šešių mėnesių koreliacija	Vienmečio koreliacija	Dviejų metų koreliacija
Fosun International	TiekėjasKlientas	0,44	0,10	-0,26	-0,25	-0,13	-

What values and corporate philosophy does New Frontier Health represent?

New Frontier Health Corp represents a set of core values and a corporate philosophy focused on providing high-quality and accessible healthcare solutions. With a strong commitment to innovation and patient-centric care, the company strives to offer comprehensive and personalized medical services. By leveraging advanced technologies and partnering with renowned medical professionals, New Frontier Health Corp aims to deliver exceptional healthcare experiences. The company's focus on continuous improvement and fostering a culture of excellence enables it to stay at the forefront of the industry, ensuring the provision of reliable and efficient healthcare services to patients.

In which countries and regions is New Frontier Health primarily present?

New Frontier Health Corp is primarily present in China and operates extensively across various regions within the country. With a strong focus on advancing healthcare services, the company has established a significant presence in key Chinese regions, including Beijing, Shanghai, and Guangdong. Through its comprehensive network of hospitals and medical centers, New Frontier Health Corp aims to provide quality and accessible healthcare solutions to individuals across China.

What significant milestones has the company New Frontier Health achieved?

New Frontier Health Corp has achieved significant milestones since its establishment. The company successfully launched its first hospital in 2005, marking its entry into the Chinese healthcare market. In 2018, New Frontier Health Corp partnered with renowned international partners to introduce advanced medical technologies and expertise. The company expanded its services and opened additional hospitals, enhancing its presence across China. New Frontier Health Corp has consistently received industry recognition for its exceptional patient care and innovative healthcare solutions. The company's commitment to quality, patient-centric approach, and continuous expansion demonstrate its remarkable achievements in improving healthcare accessibility and quality in China.

What is the history and background of the company New Frontier Health?

New Frontier Health Corp is a leading provider of high-quality healthcare services in China. Established in 2005, the company has a rich history of delivering excellent patient care and innovative medical solutions. With a mission to improve medical access and outcomes, New Frontier Health Corp offers a comprehensive range of services including hospital management, outpatient clinics, and healthcare education. The company's commitment to quality and patient-centric care has garnered a strong reputation in the industry. New Frontier Health Corp continues to expand its footprint, striving to make a positive impact on the healthcare landscape in China and beyond.

Who are the main competitors of New Frontier Health in the market?

The main competitors of New Frontier Health Corp in the market are other healthcare service providers, such as UnitedHealth Group, HCA Healthcare, and Tenet Healthcare.

In which industries is New Frontier Health primarily active?

New Frontier Health Corp is primarily active in the healthcare industry.

What is the business model of New Frontier Health?

The business model of New Frontier Health Corp focuses on operating high-quality hospitals and healthcare services in China. By providing comprehensive and advanced medical care, the company aims to meet the increasing demand for quality healthcare services in the country. New Frontier Health Corp leverages its expertise in medical management and partnerships with leading healthcare providers to deliver a patient-centered approach, ensuring the highest standard of care. Through its network of hospitals and clinics, the company offers a wide array of medical services, including surgeries, consultations, diagnostics, and inpatient care, contributing to the improvement of healthcare accessibility and patient outcomes in China.

Koks yra New Frontier Health 2024 KGV?

New Frontier Health KGV yra 26,69.

Koks New Frontier Health 2024 KUV?

New Frontier Health KUV yra 2,21.

Koks yra New Frontier Health AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis New Frontier Health yra 2/10.

Koks yra New Frontier Health 2024 pajamų dydis?

tikėtina New Frontier Health pardavimai yra 4,50 mlrd. CNY.

Kokia yra New Frontier Health 2024 pelnas?

tikėtina New Frontier Health pelnas yra 372,01 mln. CNY.

Ką daro New Frontier Health?

New Frontier Health Corp (NFH) is a leading company in the healthcare sector, offering innovative healthcare services and products in China. The company has various business divisions, including clinics, mobile healthcare services, and hospital management. One of NFH's main activities is operating clinics that provide innovative healthcare solutions and services, including health consultation and prevention services. The clinics have experienced medical staff and modern medical equipment to ensure the best possible treatment. In addition to clinics, NFH also has mobile healthcare services that cater to customer needs. These mobile services include home visits, telemedicine, and mobile pharmacies that can deliver medications directly to customers. These services allow customers to conveniently and safely access medical care and medications from home. Hospital management is another division of NFH. The company offers professional consulting services and support in operating hospitals to achieve increased efficiency and quality. The goal is to improve overall healthcare by collaborating with hospitals and medical facilities. The company also offers innovative products such as digital health platforms and AI-supported healthcare solutions. These products enable more efficient and accurate healthcare by utilizing artificial intelligence and big data analytics to provide more precise diagnoses and develop personalized treatment plans. NFH has also developed a comprehensive health insurance program that provides comprehensive coverage in case of illness. This program also offers special offers for healthcare and prevention to ensure customers stay healthy. In summary, NFH's business model is focused on offering innovative and customer-oriented healthcare services and products. The company aims to exceed customer expectations by focusing on cutting-edge medicine, technology, and research. With their extensive experience in the healthcare sector and innovative approach, NFH ensures that patient needs are prioritized and effective and high-quality healthcare is provided.

Kokia yra New Frontier Health dividendė?

New Frontier Health moka dividendą 0 CNY, kuris yra paskirstytas per išmokas per metus.

Kiek kartų New Frontier Health moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota New Frontier Health arba įmonė dividendų nemoka.

Kas yra New Frontier Health ISIN?

New Frontier Health ISIN yra KYG6461G1064.

Kas yra New Frontier Health Tickeris?

New Frontier Health akcijų simbolis yra NFH.

Kiek dividendų moka New Frontier Health?

Per paskutinius 12 mėnesių New Frontier Health išmokėjo dividendą, kurios dydis siekė . Tai atitinka maždaug dividendų grąžą. Artimiausiems 12 mėnesiams New Frontier Health tikėtina išmokės dividendus, kurie sudarys 0 CNY.

Kokia yra New Frontier Health dividendų grąža?

New Frontier Health šiuo metu yra dydžio dividendų grąža.

Kada New Frontier Health moka dividendus?

New Frontier Health moka dividendus kas ketvirtį. Jie išmokami mėnesiais.

Kokia saugi yra New Frontier Health dividendų išmokėjimas?

New Frontier Health per paskutiniuosius 0 metus kiekvienais metais mokėjo dividendus.

Kokia yra New Frontier Health dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0 CNY. Tai atitinka 0 % dividendų grąžos procentą.

Kokiame sektoriuje yra New Frontier Health?

New Frontier Health priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von New Frontier Health kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį New Frontier Health dividendą nuo 2024-08-07, kurio dydis yra 0 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-08-07.

Kada New Frontier Health paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-08-07.

Kokia buvo New Frontier Health dividendų suma 2023 metais?

2023 metais New Frontier Health išmokėjo 0 CNY dividendų.

Kokia valiuta New Frontier Health moka dividendus?

New Frontier Health dividendai yra mokami CNY.

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodasNFH

ISINKYG6461G1064

New Frontier Health akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

New Frontier Health Akcijų istorija

New Frontier Health akcijų apyvarta, EBIT, pelnas KYG6461G1064 ·

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

New Frontier Health Pajamų, pelno ir EBIT istorija.

New Frontier Health Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

New Frontier Health Akcijos Maržos KYG6461G1064 ·

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

New Frontier Health Maržų istorija

New Frontier Health akcijos apyvarta, EBIT, pelnas vienai akcijai KYG6461G1064 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

New Frontier Health Pardavimų, pelno ir EBIT istorija vienai akcijai

New Frontier Health akcija ir akcijų analizė

New Frontier Health vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

New Frontier Health įvertinimas pagal istorinį P/E, EBIT ir P/S

New Frontier Health akcijų skaičius KYG6461G1064 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

New Frontier Health Pelno prognozės

New Frontier Health Pelnų staigmenos

New Frontier Health akcijos akcininkų struktūra

New Frontier Health Tiekimo grandinė.

Dažnai užduodami klausimai apie New Frontier Health akciją